Skip to main content

Curevac N.V.(CVAC-Q)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Curevac N.V.

Friedrich-Miescher-Strasse 15
Tubingen 2M 72076 DEU
P: 49-70-71988-30
F: 719-883-1101


CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.

Key Executives

Franz-Werner HaasCEO
Pierre KemulaCFO
Igor SplawskiChief Scientific Officer
Antony BlancOther Executive Officer
Klaus EdvardsenOther Executive Officer
Malte GreuneCOO